COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Health Sciences, University of Buea, Cameroon.
Travel Med Infect Dis. 2022 May-Jun;47:102292. doi: 10.1016/j.tmaid.2022.102292. Epub 2022 Mar 18.
Despite being a global pandemic, little is known about the factors influencing in-hospital mortality of COVID-19 patients in sub-Saharan Africa. This study aimed to provide data on in-hospital mortality among COVID-19 patients hospitalized in a single large center in Cameroon.
A hospital-based prospective follow-up was conducted from March 18 to June 30, 2020, including patients >18 years with positive PCR for SARS-COV-2 on nasopharyngeal swab admitted to the Laquintinie Douala hospital COVID unit. Predictors of in-hospital mortality were assessed using Kaplan Meir survival curves and Weibull regression for the accelerated time failure model. Statistical significance was considered as p < 0.05.
Overall 712 patients (65,7% men) were included, mean age 52,80 ± 14,09 years. There were 580 (67,8% men) in-hospital patients. The median duration of hospital stay was eight days. The in-hospital mortality was 22.2%. Deceased patients compared to survivors were significantly older, had a higher temperature, respiratory rate, and heart rate, and lowest peripheral oxygen saturation at admission. After adjusting for age, sex, and other clinical patient characteristics, increased heart rate, increased temperature, decreased peripheral oxygen saturation. The critical clinical status was significantly associated with increased in-hospital mortality. In contrast, hospitalization duration greater than eight days and the use of hydroxychloroquine (HCQ) + azithromycin (AZM) therapy was associated with decreased risk of in-hospital mortality.
One in five hospitalized COVID-19 patients die in a low-middle income setting. Critical clinical status, dyspnea, and increased heart rate were predictors of in-hospital mortality. This study will serve as a prerequisite for more robust subsequent follow-up studies. Also, these results will aid in revising national guidelines for the management of COVID-19 in Cameroon.
尽管 COVID-19 是一种全球性大流行病,但人们对撒哈拉以南非洲地区 COVID-19 患者住院病死率的影响因素知之甚少。本研究旨在提供喀麦隆一家大型单一中心住院 COVID-19 患者的住院病死率数据。
2020 年 3 月 18 日至 6 月 30 日进行了一项基于医院的前瞻性随访,包括鼻咽拭子 SARS-COV-2 PCR 阳性且年龄>18 岁的患者,这些患者被收治到拉奎廷尼埃杜阿拉医院 COVID 病房。使用 Kaplan-Meir 生存曲线和 Weibull 回归加速时间失效模型评估住院病死率的预测因素。统计显著性定义为 p<0.05。
共纳入 712 例患者(65.7%为男性),平均年龄为 52.80±14.09 岁。580 例(67.8%为男性)患者住院。中位住院时间为 8 天。住院病死率为 22.2%。与存活者相比,死亡患者年龄较大,入院时体温、呼吸频率和心率较高,外周血氧饱和度较低。在校正年龄、性别和其他临床患者特征后,心率增加、体温升高、外周血氧饱和度降低与住院病死率增加显著相关。危急临床状态与住院病死率增加显著相关。相比之下,住院时间大于 8 天和使用羟氯喹(HCQ)+阿奇霉素(AZM)治疗与住院病死率降低相关。
在中低收入国家,每 5 例住院 COVID-19 患者中就有 1 例死亡。危急临床状态、呼吸困难和心率增加是住院病死率的预测因素。本研究将作为后续更稳健随访研究的前提。此外,这些结果将有助于修订喀麦隆 COVID-19 管理国家指南。